The Mechanism for Abdominal Pain in IBS5-7
VISCERAL HYPERSENSITIVITY AND ALTERED CORTICAL PERCEPTION IN IBS5-7
IBS is thought to be associated with visceral hypersensitivity and pain caused by hyperactivity of colonic pain fibers located in the submucosa of the gut. These fibers signal to the pain-sensing regions of the brain, causing a disconnect between brain-gut communication that results in the brain perceiving gut signals more strongly than usual and sending signals to the gut that disturb intestinal functioning.5-7
ROME IV IBS CRITERIA8
Recurrent abdominal pain at least 1 day per week, on average, associated with 2 or more of the following criteria:*
- Related to defecation
- Associated with a change in frequency of stool
- Associated with a change in form (appearance) of stool
Rome Clinical Considerations
The Rome Foundation suggests for clinical practice, a diagnosis may be made with a lower symptom frequency and a shorter duration (8 weeks or more) than those required above, provided that symptoms are bothersome for the patient (i.e., interfering with daily activities/quality of life) and there is clinical confidence that other diagnoses have been sufficiently ruled out.
*Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis.
Downloadable Resources for You and Your Patients
An open dialogue focused on understanding the patient’s most bothersome symptoms may help reduce treatment delays and improve treatment expectations. The resources here are designed to help start the conversation and help with patient education and treatment management.
BSFS=Bristol Stool Form Scale; GI=gastrointestinal; IBS=irritable bowel syndrome; IBS-C=irritable bowel syndrome with constipation; IBS-D=irritable bowel syndrome with diarrhea; MOA=mechanism of action.
References: 1. Chey WD et al. JAMA. 2015;313(9):949-958. doi:10.1001/jama.2015.0954 2. Drossman DA. Gastroenterology. 2016;150:1262-1279. doi:10.1053/j.gastro.2016.02 3. Holtmann G et al. Dig Dis. 2017;35:5-13. doi:10.1159/000485409 4. Radovanovic-Dinic B et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018;162(1):1-9. doi:10.5507/bp.2017.057 5. Kim SY et al. J Neurogastroenterol Motil. 2018;24(4):544-558. doi:10.5056/jnm18082 6. Saha L. World J Gastroenterol. 2014;20(22):6759-6773. doi:10.3748/wjg.v20.i22.6759 7. Quigley EMM. J Clin Med. 2018;7(6):1-8. doi:10.3390/jcm7010006 8. Drossman DA et al. Gastroenterology. 2022;162(3):675-679. doi:10.1053/j.gastro.2021.11.01911